RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Genomic Vision - Stock

Genomic Vision Market capitalization 2024

Genomic Vision Market capitalization

126,964.96 EUR

Ticker

GV.PA

ISIN

FR0011799907

WKN

A110TM

In 2024, Genomic Vision's market cap stood at 126,964.96 EUR, a -88.62% increase from the 1.12 M EUR market cap in the previous year.

The Genomic Vision Market capitalization history

YEARREVENUE (undefined EUR)GROSS MARGIN (%)NET INCOME (undefined EUR)
20221.03-165,01-6,790
20210.99-122,94-4,998
20201.08-108,76-5,177
20191.77-100,56-4,608
20181.11-235,94-6,898
20172.1433,02-9,071
20161.5752,00-8,613
20152.3695,51-4,338
20143.4698,41-2,156
20132.8934,60-1,070
20122.921,72-1,890
20113.8239,7950

Genomic Vision Aktienanalyse

What does Genomic Vision do?

Genomic Vision is a biotechnology company that was founded in 2004. It is based in Bagneux, France, and develops and markets innovative molecular diagnostic tools and services based on its patented platform technology. The company's business model is based on collaboration with large pharmaceutical and diagnostic companies to help accelerate their product development and improve their clinical outcomes. Genomic Vision specializes in genetic diagnostics and offers a platform for analyzing DNA structures, allowing for the detection and quantification of genetic changes associated with various diseases such as cancer, neurological disorders, and rare diseases. The company also offers customized solutions and services tailored to the specific needs of its customers. In addition, Genomic Vision licenses its technology and patents to pharmaceutical companies and other organizations. The company has already partnered with Hitachi High-Technologies in Japan to market its platform for cancer monitoring and to develop molecular tests for cancer and other diseases. Genomic Vision has also introduced products such as the FiberVision system for visualizing and analyzing DNA fibers and is working on a new diagnostic test for precise diagnosis of autism and other neurological disorders. The company aims to improve the diagnosis of genetic diseases and advance genomic research. With its patented technology and expertise in molecular diagnostics, Genomic Vision is well positioned to drive the development of new and innovative products. Overall, Genomic Vision is an emerging company focused on the development of molecular diagnostic tools and services, and has a solid foundation in DNA visualization and analysis. With its innovative products and services, the company is well positioned to drive the growth of the molecular diagnostics market and establish itself as a key player in the field. Genomic Vision ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Market capitalization Details

Exploring Genomic Vision's Market Capitalization

Genomic Vision's market capitalization represents the total dollar market value of the company’s outstanding shares of stock. It is calculated by multiplying the company's shares outstanding by the current market price of one share. This metric is a vital indicator of a company’s size, strength, and overall market value.

Year-to-Year Comparison

A yearly comparison of Genomic Vision's market capitalization provides investors and analysts insights into its growth and valuation trends. An increase signifies market confidence and business expansion, while a decrease may point towards declining market value or business contractions.

Impact on Investments

Genomic Vision's market capitalization plays a pivotal role in investment decisions. It aids investors in assessing the company's risk and return profiles. Larger companies are often considered more stable but may offer lower growth potential, while smaller companies might offer significant growth prospects but come with higher risk.

Interpreting Market Capitalization Fluctuations

Variations in Genomic Vision’s market capitalization can be attributed to several factors, including changes in stock price, outstanding shares, and market sentiment. Understanding these fluctuations helps investors evaluate the company's current standing and future potential in the competitive landscape.

Frequently Asked Questions about Genomic Vision Stock

What is the current Genomic Vision market capitalization?

The current market capitalization of Genomic Vision is 126,964.96 EUR.

What is market capitalization?

The market capitalization (German: Marktkapitalisierung, English: market capitalization, abbreviated as market cap, also known as stock exchange capitalization or market value) is the calculated total value of all shares of a publicly traded company like Genomic Vision.

How has the market capitalization of Genomic Vision developed in recent years?

The market capitalization of Genomic Vision has increased/decreased by -88.62% compared to the previous year.

What does market capitalization mean for investors?

The market capitalization of a company reflects the current market consensus on the value of the equity of a publicly traded company.

Why is market capitalization an important indicator for investors?

The market capitalization of a company reflects the current market consensus on the value of a publicly traded company's equity. It is determined by the supply and demand for the company's shares. Market capitalization is thus significantly influenced by expectations in the stock market regarding the future earnings power of the company, and as such, it can undergo significant fluctuations.

Why does the market capitalization fluctuate?

The market capitalization fluctuates along with the stock price, as the market capitalization is calculated based on the current price and the number of outstanding shares.

What role does market capitalization play in the valuation of Genomic Vision?

In order to compare the value of companies, it is helpful to consider not only the market capitalization but also the net debt of a company. A potential buyer of the entire company would also acquire the debts of the company. The enterprise value is the total value of a company or a stock corporation. The net financial indebtedness of the company is added to the market capitalization.

Does the market capitalization influence the performance of Genomic Vision?

There is no verifiable long-term evidence or study that stocks with a specific market capitalization (whether Mega/Large/Mid/Small Cap) would consistently yield significantly higher returns than others. There are occasional small studies (few stocks, short investment period) suggesting that certain classes may perform better or have higher risk, but none of them are 1. conclusive (cause-effect relationship is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).

Does the market capitalization of Genomic Vision have an influence on indices?

Some stock indices use market capitalization as index weighting. Stocks with a higher market capitalization are also weighted higher in the index. This is in contrast to equally weighted indices (all stocks have the same weighting) and free float weighted indices (market capitalization weighting, but only with the number of shares in free float).

How much dividend does Genomic Vision pay?

Over the past 12 months, Genomic Vision paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Genomic Vision is expected to pay a dividend of 0 EUR.

What is the dividend yield of Genomic Vision?

The current dividend yield of Genomic Vision is .

When does Genomic Vision pay dividends?

Genomic Vision pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Genomic Vision?

Genomic Vision paid dividends every year for the past 0 years.

What is the dividend of Genomic Vision?

For the upcoming 12 months, dividends amounting to 0 EUR are expected. This corresponds to a dividend yield of 0 %.

In which sector is Genomic Vision located?

Genomic Vision is assigned to the 'Health' sector.

Wann musste ich die Aktien von Genomic Vision kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Genomic Vision from 6/19/2024 amounting to 0 EUR, you needed to have the stock in your portfolio before the ex-date on 6/19/2024.

When did Genomic Vision pay the last dividend?

The last dividend was paid out on 6/19/2024.

What was the dividend of Genomic Vision in the year 2023?

In the year 2023, Genomic Vision distributed 0 EUR as dividends.

In which currency does Genomic Vision pay out the dividend?

The dividends of Genomic Vision are distributed in EUR.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Genomic Vision

Our stock analysis for Genomic Vision Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Genomic Vision Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.